Marex (MRX) Cash & Equivalents (2022 - 2025)

Marex's Cash & Equivalents history spans 4 years, with the latest figure at $2.9 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 12.7% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $2.9 billion, up 12.7%, while the annual FY2025 figure was $2.9 billion, 12.7% up from the prior year.
  • Cash & Equivalents reached $2.9 billion in Q4 2025 per MRX's latest filing, up from $2.6 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.9 billion in Q4 2025 to a low of $910.1 million in Q4 2022.
  • Average Cash & Equivalents over 4 years is $2.0 billion, with a median of $2.0 billion recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 72.34% in 2024, then grew 12.7% in 2025.
  • A 4-year view of Cash & Equivalents shows it stood at $910.1 million in 2022, then surged by 63.0% to $1.5 billion in 2023, then surged by 72.34% to $2.6 billion in 2024, then rose by 12.7% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for MRX's Cash & Equivalents are $2.9 billion (Q4 2025), $2.6 billion (Q4 2024), and $1.5 billion (Q4 2023).